A novel imaging agent, 68Ga-FAPI, can reduce the number of false-positive PET/CT findings among cancer patients recently vaccinated for COVID-19. New research published ahead of print in the Journal of Nuclear Medicine shows ...
Jan 11, 2023
0
13
CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR ...
Apr 12, 2022
0
6
From HIV to Ebola, and now COVID-19, inequality in access to medicines and vaccines has been prevalent in developing countries for decades.
Mar 30, 2022
0
2
In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the Food and Drug Administration (FDA), an additional booster dose of any of ...
Jan 26, 2022
0
139
After an initial wave of enthusiasm among parents to have their children vaccinated against COVID-19, there has been a noticeable uptick in parental resistance since June that is contributing to a slowing of the teen vaccination ...
Dec 15, 2021
0
2
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases. ...
Nov 1, 2021
0
2
Despite many advances in treating the COVID-19 virus there remains no specific cure for patients with infection. This is especially the case with hospitalized patients who end up in the ICU requiring mechanical ventilation ...
Oct 26, 2021
0
28
Vaccines are mostly synonymous with needles, an efficient and effective way to provide immunity to myriad infections. As COVID-19 vaccination efforts roll out across the U.S. and the world, some experts believe that a vaccine ...
Jun 9, 2021
0
1
COVID-19 vaccination rates must reach 80% to achieve herd immunity, but only about 60% of Americans are willing to be vaccinated, according to the Pew Research Center. Stanford physician and economist Kevin Schulman suggests ...
Jan 8, 2021
0
6
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Aug 27, 2020
0
100
